Business
Beijing, China. Glowing Company Logo Of Puma Close Up View. Puma Se Is German Multinational Corporation Who Design And Manufacture Athletic And Casual Footwear. Sports Lifestyle
Getty Images
Ready to pounce?

With Puma’s stock under pressure, Chinese giants are circling the storied brand

With 77 years of history behind the brand, 2025 might just be Puma’s worst, as losses have piled up over the last year. At least the company’s new elite running shoe is a winner.

Claire Yubin Oh

Last week, Bloomberg reported that Fila and Jack Wolfskin owner Anta Sports was mulling a potential takeover of Puma — sending shares of the German sportswear maker up some 19% on Thursday, the most since late 2001. And Anta Sports isn’t the only suitor eyeing the discounted Puma, per sources cited in the report, as rival Chinese apparel firm Li Ning and Japan’s Asics might also be interested.

That news finally gave investors something to smile about, but it’s still nowhere close to repairing the damage of Puma’s miserable year, in which the stock has shed more than 50%. Furthermore, any potential sale is unlikely to be an easy one, as the Pinault family, which owns a 29% stake in the company, could prove an obstacle to any sale.

Puma’s losing money
Sherwood News

No room to swing a big cat

Puma has long tried to straddle the fine line between athletic apparel and fashion appeal. But squeezed by new competition in the running space from brands like On and Hoka, and facing fading customer enthusiasm even with heavy discounts, the brand’s profits have vanished. Over the last four quarters, the company has racked up the equivalent of nearly ~$330 million worth of losses, and its market cap has shrunk from nearly $20 billion in 2021 to just $3.5 billion at the time of writing.

Under its new CEO, Puma aims to return to growth by 2027 and become one of the top three sports brands globally — but with swelling excess inventory and a customer base used to seeing marked-down prices, that’s not going to be easy, and the company has already slashed ~1,400 jobs this year.

One bright spot — which reportedly shocked the people at Puma as much as everyone else — is the company’s latest elite running shoe, Fast-R, which blew the competition away in one study.

More Business

See all Business
business

Ford reportedly in talks to buy hybrid vehicle batteries from Chinese auto giant BYD

Detroit’s Ford and China’s BYD are said to be in ongoing talks to partner on an agreement that would see Ford buy hybrid vehicle batteries from BYD, according to reporting from The Wall Street Journal.

The report comes just days after President Trump toured a Ford factory in Michigan and implied openness to Chinese automakers coming to the US.

“If they want to come in and build a plant... that’s great, I love that,” Trump said on January 13. “Let China come in, let Japan come in.”

Last week, China’s Geely Automobile Holdings said it expects to make an announcement about expanding into the US within the next three years. Chinese carmakers currently face huge tariffs and software restrictions, effectively barring their vehicles from the US.

Ford has doubled down on hybrid vehicles amid high EV costs and the end of federal EV tax credits. The automaker is currently building a battery plant in Michigan where it plans to use tech from Chinese battery maker CATL.

“If they want to come in and build a plant... that’s great, I love that,” Trump said on January 13. “Let China come in, let Japan come in.”

Last week, China’s Geely Automobile Holdings said it expects to make an announcement about expanding into the US within the next three years. Chinese carmakers currently face huge tariffs and software restrictions, effectively barring their vehicles from the US.

Ford has doubled down on hybrid vehicles amid high EV costs and the end of federal EV tax credits. The automaker is currently building a battery plant in Michigan where it plans to use tech from Chinese battery maker CATL.

Still life of Ozempic and Wegovy with weight scale.

Lawsuit alleges Lilly, Novo locked up telehealth to kill compounded GLP-1s

Novo Nordisk CEO Mike Doustdar estimated that around 1.5 million US patients are using compounded versions of the company’s drugs.

Handshake

Big Pharma enters 2026 with an appetite for deals

At the JPMorgan Healthcare Conference, biotechs and Big Pharma signaled they’re primed for M&A this year, after a big year for deals in 2025.

Latest Stories

Sherwood Media, LLC produces fresh and unique perspectives on topical financial news and is a fully owned subsidiary of Robinhood Markets, Inc., and any views expressed here do not necessarily reflect the views of any other Robinhood affiliate, including Robinhood Markets, Inc., Robinhood Financial LLC, Robinhood Securities, LLC, Robinhood Crypto, LLC, or Robinhood Money, LLC.